Clinical Trial Update: Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of Bryostatin-1 for Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Bryostatin-1 (bryostatin-1)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Lymphoma | Phase 2 | Status: COMPLETED